Paromomycin sulfate indications and usage: Difference between revisions
Jump to navigation
Jump to search
Gerald Chi (talk | contribs) mNo edit summary |
Gerald Chi (talk | contribs) |
||
| Line 4: | Line 4: | ||
==Indications and Usage== | ==Indications and Usage== | ||
Paromomycin sulfate is indicated for intestinal | Paromomycin sulfate is indicated for intestinal [[amebiasis]]—acute and chronic (NOTE—It is not effective in extraintestinal amebiasis); management of hepatic coma—as adjunctive therapy. <ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = PAROMOMYCIN SULFATE CAPSULE [CARACO PHARMACEUTICAL LABORATORIES, LTD.] | url =http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=22494bde-a53e-4b3c-a89b-0ccda341f28f | publisher = | date = | accessdate = }}</ref> | ||
==References== | ==References== | ||
Latest revision as of 00:46, 31 December 2013
| Paromomycin Sulfate |
|---|
| PAROMOMYCIN SULFATE capsule® FDA Package Insert |
| Description |
| Clinical Pharmacology |
| Indications and Usage |
| Contraindications |
| Warnings and Precautions |
| Adverse Reactions |
| Dosage and Administration |
| How Supplied |
| Labels and Packages |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Indications and Usage
Paromomycin sulfate is indicated for intestinal amebiasis—acute and chronic (NOTE—It is not effective in extraintestinal amebiasis); management of hepatic coma—as adjunctive therapy. [1]
References
Adapted from the FDA Package Insert.